Getting Biotechs GlobalReady

THREE Decades Of Deep Clinical Research Management

GlobalReady offers decades of deep clinical research management experience across Australia, New Zealand, Asia, North America, and Europe. More than 90 biotech clients have already taken advantage of Avance Clinical’s GlobalReady program.

In addition, the attractive 43.5% rebate on clinical spend in Australia offers our clients the opportunity to start their pre-clinical and EARLY PHASE trials quickly in Australia (no IND required), then expand to North America, Asia, and Europe for later phases.

This unique GlobalReady model is designed to extend biotechs’ investments so they can achieve greater clinical development milestones with reduced spend, all with the assurance of FDA-accepted data.

How GlobalReady Delivers Across All Phases

GlobalReady is designed to support biotechs from their early pre-clinical through to later phases.

All with the one CRO, across the globe, and leveraging the right site relationships and delivering access to patient populations.

Multi-regional focus from the start

With the pre-clinical ClinicReady in-house scientific and regulatory affairs specialists – PhD-qualified professionals with three decades of industry and academic research experience – biotechs are assured of the right start to their drug development program.

• Australia and New Zealand offer fast start-up

  • Ideal for early phase then across to Asia, USA, or Europe

• No IND required

  • Australia offers early phase trials without requiring an IND

• Rebate on clinical trial spend in Australia

  • Rebate on clinical trial spend in Australia

• Tap the rebate for later studies

  • In many cases the rebate can apply across all phases

Planning for later phases

The global Avance Clinical team, featuring integrated in-house scientific and regulatory affairs, ensures a streamlined program that meets the approval of all international and regional regulatory authorities.

• Integrated global team

  • Streamlined processes designed for success

• Drug Development Program

  • Seamless progress across later phases

• Multi-regional expansion

  • Expertise and site relationships across regions

• Regulatory authority engagement

  • PhD-qualified professionals with three decades of regulatory experience

One CRO across all phases

Award-winning Avance Clinical delivers a comprehensive drug development solution across all phases with expert planning and implementation.

• Seamless service delivery from the one CRO

  • Integrated areas of expertise in a global framework

• Local and regional experience and knowledge

  • Specialists for advice at every stage

• Global patient population reach

  • Accessing patients for rapid recruitment

• Partner site networks

  • Site selection based on deep experience

WHY BIOTECHS CHOOSE AVANCE CLINICAL

More than three decades of deep clinical research management experience, Avance Clinical is the largest
specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand, Asia and North America for international biotechs.

• 43.5% REBATE

• 5-6 Wks START-UP TIME

• 100% CAPABILITIES

• FDA COMPLIANT RESEARCH